New York will receive $38.5 million in a settlement with Mylan over the company's alleged underpayment of rebates to Medicaid for its EpiPen anti-allergy auto-injector.
By Claire Hughes, Times Union
Thu, 08/17/2017 - 6:07pm
New York will receive $38.5 million in a settlement with Mylan over the company's alleged underpayment of rebates to Medicaid for its EpiPen anti-allergy auto-injector.